THERAGENLIV - Project funded within Romania’s National Recovery and Resilience Plan

 

Pillar III. Smart, sustainable and inclusive growth, including economic cohesion, jobs, productivity, competitiveness, research, development, and innovation, and a well-functioning internal market with strong small and medium-sized enterprises (SMEs)

Component C9. Support for the Private Sector, Research, Development and Innovation

Section I8. “Development of a program to attract highly specialized human resources from abroad in research, development and innovation activities”

 

Project code:                   PNRR-III-C9-2022-I8-197

Contract number:            760059/23.05.2023

Implementation period:  36 months (23.05.2023 – 30.06.2026)

Budget:                            7.000.000 RON / 1.417.290,94 EUR

 

Project title

Enhancing the endogenous anti-oxidant and cholesterol removal potential by gene editing in fatty liver disease; pre-clinical studies

Acronym

THERAGENLIV